학술논문
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Document Type
journal article
Author
Ghia, Paolo; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kaplan, Polina; Kraychok, Iryna; Illes, Arpad; de la Serna, Javier; Dolan, Sean; Campbell, Phillip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric; Lee, Jae Hoon; Liang, Wei; Patel, Priti; Quah, Cheng; Jurczak, Wojciech
Source
Journal of Clinical Oncology; 9/1/2020, Vol. 38 Issue 25, p2849-2861, 14p
Subject
Language
ISSN
0732183X